Biotech industry asked for opinions on NBAF module
DHS officials issued a request for information concerning the planned Biotechnolgy Development Module, which is intended to attract animal health industry involvement and encourage public-private partnerships for the development of countermeasures, according to HSToday.us.
"The proposed BDM is intended to produce small scale GMP-compliant biological countermeasures for supporting efficacy studies and early phase clinical trials in response to DHS and USDA program requests," DHS said, HSToday.us reports. "The BDM has been designed to manufacture experimental diagnostics, biologics and therapeutics designed for the detection, control and eradication of foreign animal diseases in the United States."
Several government agencies, including the U.S. Department of Agriculture and the Office of National Laboratories, have issued invitations to examine the BDM plans, offer their thoughts and propose alternatives.
The various agencies will accept responses until the beginning of May. They have scheduled a BDM workshop in mid-march at the Olathe, Kansas, campus of Kansas State University.
DHS has specifically asked for respondents to weigh in on the scope of the BDM, its configuration and its operational requirements. The department has also asked respondents to assess whether the BMD can fulfill other needs and whether the industry would be interested in using it, according to HSToday.us.